Depressive Disorders - APAC | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$6.03bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.37%, resulting in a market volume of US$6.46bn by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$36.26 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in APAC is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in the APAC region are increasingly seeking effective and accessible treatment options for Depressive Disorders. They are looking for medications and therapies that can provide relief from symptoms such as persistent sadness, loss of interest, and changes in appetite or sleep patterns. Additionally, customers prefer treatment options that have minimal side effects and can be easily incorporated into their daily routines.

Trends in the market: One of the key trends in the Depressive Disorders market in APAC is the growing adoption of digital mental health solutions. With the increasing penetration of smartphones and internet connectivity in the region, customers are turning to mobile applications, online therapy platforms, and virtual support groups for managing their mental health. These digital solutions offer convenience, privacy, and accessibility, allowing customers to receive support and treatment from the comfort of their homes. Another trend in the market is the rising demand for personalized treatment approaches. Customers are seeking tailored solutions that address their unique symptoms and circumstances. This has led to the development of precision medicine in the field of Depressive Disorders, where treatments are customized based on genetic, biological, and environmental factors. Personalized treatment approaches offer better outcomes and reduce the risk of adverse effects, driving their popularity in the APAC market.

Local special circumstances: The Depressive Disorders market in APAC is influenced by several local special circumstances. One such circumstance is the stigma surrounding mental health in many countries in the region. Despite the growing awareness about mental health issues, there is still a significant social stigma attached to seeking help for Depressive Disorders. This stigma often prevents individuals from openly discussing their symptoms or seeking professional treatment. As a result, the market for Depressive Disorders in APAC is characterized by a large undiagnosed and untreated population.

Underlying macroeconomic factors: The growth of the Depressive Disorders market in APAC is also influenced by underlying macroeconomic factors. Rapid urbanization, changing lifestyles, and increasing disposable incomes have contributed to the rising prevalence of Depressive Disorders in the region. Additionally, the aging population in APAC countries has led to a higher incidence of Depressive Disorders, as older adults are more susceptible to developing mental health conditions. These demographic shifts and socioeconomic factors have created a significant market opportunity for pharmaceutical companies and mental health service providers in the APAC region. In conclusion, the Depressive Disorders market in APAC is witnessing growth due to changing customer preferences, emerging trends such as digital mental health solutions and personalized treatment approaches, as well as local special circumstances including stigma surrounding mental health. The underlying macroeconomic factors of rapid urbanization, changing lifestyles, increasing disposable incomes, and an aging population further contribute to the expansion of the market in the APAC region.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.